MedPath

More Added Value of Therapeutic Education in the Management of Patients With Rheumatoid Arthritis (ETP-PR)

Not Applicable
Terminated
Conditions
Rheumatoid Arthritis
Interventions
Other: immediate therapeutic education
Other: therapeutic education delayed
Registration Number
NCT01564147
Lead Sponsor
Nantes University Hospital
Brief Summary

Taking into account the recommendations of the Health Authority \[1\] and the application of patients' associations, we have structured a course of therapeutic education includes three stages for patients with rheumatoid arthritis and followed at Nantes University Hospital. Step 1: initial interview with a nurse patient education for diagnosis and education with the patient to choose three subjects from among 10 offered him problematic; Step 2: Orientation in an educational path that provides access to 6 months group workshops (3 maximum) and / or interviews tailored to the three selected topics; Step 3: final interview with a nurse said therapeutic education formative assessment to take stock. The main objective of our work is to ensure that the patient finds it easier solutions to the three problematic topics him after 6 months of education after six months without treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • Patient presenting at clinics for Rheumatology or the Rheumatology Day Hospital at the University Hospital or hospitalized in the department of Rheumatology
  • Men or women
  • Having signed the consent
  • major
  • Affiliated to social security or covered by the CMU
  • Patient with rheumatoid arthritis meeting the ACR criteria
  • Patient with rheumatoid arthritis stable for at least 6 months (change in DAS 28 <1.2)
Exclusion Criteria
  • Patient can not understand the information
  • Patient confined to bed or chair, unable to care for himself or not doing with difficulty
  • pregnant patient
  • minors
  • Adults under guardianship

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Immediate Education therapeuticimmediate therapeutic educationAccess to the course of immediate therapeutic education
therapeutic education delayedtherapeutic education delayedGroup receiving therapeutic education 6 months later (control group)
Primary Outcome Measures
NameTimeMethod
EVA measures the overall ability to find solutions applicable to their situation12 months

Investigate whether, overall, the patient is more easily applicable solutions to the situation after six months of therapeutic education after six months without therapeutic education for three problems identified after the initial filling of the questionnaire (controls ) and after the initial interview with the nurse (test group)

Secondary Outcome Measures
NameTimeMethod
Self-efficacy against a disease flare (EVA), self-efficacy against a side effect of treatment (EVA)12 months

Perceived self-efficacy compared to rheumatoid arthritis

RAPID score 4 (scale)12 months

Scalability of rheumatoid arthritis

Knowledge (score / 10) treatments for rheumatoid arthritis, knowledge (note/10) signs of a flare of rheumatoid arthritis.12 months

Skills that we consider indispensable

EVA measuring fatigue12 months

Fatigue

Dosage Cortancyl or Solupred.12 months

Use of steroids

Number of visits to physician, rheumatologist at at therapist, psychiatrist, occupational physician, number of hospitalizations, number of meetings with occupational therapist, social worker, dietician, physiotherapist, psychologist...12 months

Consumption of medical and paramedical

Patient satisfaction with respect to information received, the caller and the improvement in different areas of health (EVA)12 months

Satisfaction with patient education

Attendance at meetings / workshops offered after the initial diagnosis.12 months

Membership

EVA measures the ability to find solutions applicable to their situation for each of the three problems identified.12 months

Ability to find solutions applicable to their situation for each of the three problems identified

Evaluation Test of adherence of Girerd12 months

Observance

Duration of morning stiffness in minutes or hours.12 months

Duration of stiffness

CRP and VS12 months

Biological criteria

Beck Scale12 months

Depression

Scale of STAI S Scale of STAI S12 months

Anxiety

Trial Locations

Locations (1)

Maugars

🇫🇷

Nantes, France

© Copyright 2025. All Rights Reserved by MedPath